You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 8, AUGUST 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cough and ACE Inhibitors

Steven R. Simon; Henry R. Black, MD; Marvin Moser, MD; Wendy E. Berland, MPH

Arch Intern Med. 1992;152(8):1698-1700.


Abstract

To assess the prevalence of cough as a side effect of angiotensin-converting enzyme inhibitor antihypertensive therapy, we reviewed 300 consecutive patient charts from a private practice and 200 consecutive patient charts from a university-based referral center for hypertension. Incidence of definite angiotensin-converting enzyme inhibitorinduced cough in the private practice was 25% and in the university practice, 7%, with an additional 6% of university-practice patients reporting a possible angiotensin-converting enzyme—inhibitor induced cough. This incidence is considerably greater than listed in the Physicians' Desk Reference. Reasons for the variability in incidence as reported in the literature are explored. Clinicians must be aware of this potentially disturbing side effect of angiotensin-converting enzyme inhibitors to avoid expensive and unnecessary diagnostic evaluations.

(Arch Intern Med. 1992;152:1698-1700)



Author Affiliations

From the Section of Preventive Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn.


Footnotes

Accepted for publication March 9, 1992.

Reprint requests to Davis Avenue Medical Center, 33 Davis Ave, White Plains, NY 10605 (Dr Moser).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An Empiric Integrative Approach to the Management of Cough: ACCP Evidence-Based Clinical Practice Guidelines
Pratter et al.
Chest 2006;129:222S-231S.
ABSTRACT | FULL TEXT  

Treatment of Systemic Hypertension in Patients With Pulmonary Disease: COPD and Asthma
Dart et al.
Chest 2003;123:222-243.
ABSTRACT | FULL TEXT  

Iron Supplementation Inhibits Cough Associated With ACE Inhibitors
Lee et al.
Hypertension 2001;38:166-170.
ABSTRACT | FULL TEXT  

Pharmacodynamics and Pharmacokinetics of Irbesartan in Patients With Mild to Moderate Hypertension
Marino et al.
J CARDIOVASC PHARMACOL THER 1999;4:67-75.
ABSTRACT  

Angiotensin-Converting Enzyme Inhibitor-Induced Cough
Cheng
Arch Intern Med 1993;153:782-782.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.